ELOXX PHARMACEUTICALS, INC. Earnings Per Share (Basic)
ELOXX PHARMACEUTICALS, INC. (ELOX) reported Earnings Per Share (Basic) of -$0.66 per share for the 3-month period ending 2026-06-30, per its S-1 filed 2026-09-11.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-09-11
- ELOXX PHARMACEUTICALS, INC. earnings per share, basic for the quarter ending 2026-06-30 was -$0.66.
- ELOXX PHARMACEUTICALS, INC. earnings per share, basic for the quarter ending 2026-03-31 was -$0.86.
- ELOXX PHARMACEUTICALS, INC. earnings per share, basic for the quarter ending 2025-06-30 was -$5.45.
- ELOXX PHARMACEUTICALS, INC. earnings per share, basic for the quarter ending 2025-03-31 was -$4.94.
- ELOXX PHARMACEUTICALS, INC. earnings per share, basic for fiscal 2022 was -$16.65.
- ELOXX PHARMACEUTICALS, INC. earnings per share, basic for fiscal 2021 was -$38.15.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.66 S-1 · filed 2026-09-11 | -$1.48 S-1 · filed 2026-09-11 | ||||||
| 2026-03-31 | -$0.86 S-1/A · filed 2026-06-04 | -$0.08 10-Q · filed 2026-05-05 | ||||||
| 2025-12-31 | -$5.34 S-1 · filed 2026-09-11 | -$0.49 10-K · filed 2026-03-17 | ||||||
| 2025-06-30 | -$5.45 S-1 · filed 2026-09-11 | -$10.39 S-1 · filed 2026-09-11 | ||||||
| 2025-03-31 | -$4.94 S-1/A · filed 2026-06-04 | -$0.45 10-Q · filed 2026-05-05 | ||||||
| 2024-12-31 | -$9.20 S-1 · filed 2026-09-11 | -$0.84 10-K · filed 2026-03-17 | ||||||
| 2023-12-31 | -$72.98 S-1 · filed 2026-09-11 | -$6.63 10-K · filed 2026-03-17 | ||||||
| 2023-09-30 | -$1.31 10-Q · filed 2023-11-13 | -$5.96 10-Q · filed 2023-11-13 | ||||||
| 2023-06-30 | -$1.96 10-Q · filed 2023-08-11 | -$4.83 10-Q · filed 2023-08-11 | ||||||
| 2023-03-31 | -$2.88 10-Q · filed 2023-05-12 | |||||||
| 2022-12-31 | -$16.65 10-K · filed 2023-03-31 | |||||||
| 2022-09-30 | -$3.47 10-Q · filed 2023-11-13 | -$0.09 10-Q · filed 2022-11-10 | -$13.73 10-Q · filed 2023-11-13 | -$0.34 10-Q · filed 2022-11-10 | ||||
| 2022-06-30 | -$4.90 10-Q · filed 2023-08-11 | -$0.12 10-Q · filed 2022-08-12 | -$10.27 10-Q · filed 2023-08-11 | -$0.26 10-Q · filed 2022-08-12 | ||||
| 2022-03-31 | -$5.36 10-Q · filed 2023-05-12 | |||||||
| 2021-12-31 | -$38.15 10-K · filed 2023-03-31 | |||||||
| 2021-09-30 | -$0.11 10-Q · filed 2022-11-10 | -$0.85 10-Q · filed 2022-11-10 | ||||||
| 2021-06-30 | -$0.54 10-Q · filed 2022-08-12 | -$0.84 10-Q · filed 2022-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Tevogen Inc. (TVGN) | United States | $0.049B |